American Pharma Companies
- All
- News
-
Indian Envoy Meets Top CEOs Of US To Help Country In Covid Crisis
The Indian envoy in the US is having an intense engagement with the CEOs of top American companies, particularly from the pharma sector, to help India get the necessary medical equipment and drugs to successfully combat the COVID-19 pandemic.
-
India Reaches Out To US Companies Over Investment In Pharma Sector
India has reached out to top American pharma companies seeking investment in the country's pharmaceutical and medical devices sector, which gains urgency in view of a devastating second wave of the coronavirus pandemic.
-
US Pharma Firm Gilead To Donate 4.5 Lakh Remdesivir Vials To India
American biopharmaceutical company Gilead has announced steps to expand the availability of remdesivir, a key therapeutic medicine used in the treatment of COVID-19 patients, in India.
-
India May Not Get Pfizer Covid Vaccine, Cleared By UK, Anytime Soon: Sources
The coronavirus vaccine developed by American pharma giant Pfizer, which was cleared by the United Kingdom Wednesday and will be rolled out to the public early next week, is unlikely to be available in India at this time, sources have told NDTV
-
After H-1B, Strong Rupee The New Worry For Indian Tech Companies
For information technology and drug companies already contending with an American clampdown on working visas and a wave of unfavorable inspections by the U.S. Food and Drug Administration, rupee strength is another headache.
-
Natco Jumps 9% As Partner Mylan Inc Gets USFDA Nod
Natco Pharma shares surged nearly 9 per cent on Friday after the company said its marketing partner Mylan Inc has received tentative approval from the US health regulator for selling generic Sorafenib tablets, used for cancer treatment, in the American market.
-
Foreign Investors Holding In BSE200 Companies Drops To $291 Billion In Q4
Foreign Portfolio Investors (FPIs) have lowered their holding in BSE-200 companies to $291 billion during the January-March quarter and heavy selling was seen in sectors like banking and pharma, says a report.
-
Aurobindo Pharma Gets Final USFDA Nod For Anti-viral Drug
Aurobindo Pharma has received final approval from the US health regulator to manufacture and market anti-viral Valganciclovir tablets in the American market.
-
Cipla Inks Pact With US Firm for Post-Operative Pain Treatment Product
Drug major Cipla has inked a pact with US-based BioQ Pharma for registration and commercialisation of the American company's Ropivacaine infusion system, used in treating post-operative pain, in India.
-
Brazil's Downgrade to 'Junk' Hits Indian Pharma, Power Shares
Standard & Poor's downgrade of Brazil to "junk" hit those Indian companies that have exposure to the troubled Latin American country.
-
US Regulator Issues Import Alert on Aarti Drugs' 2 Plants
Aarti Drugs on Tuesday said its two manufacturing facilities have received import alert from the US Food and Drug Administration, a development which could impact the company's exports to the American market.
-
Indian Pharma Firms Should Tap Latin American Markets: Barclays
Indian pharmaceutical companies need to focus on the Latin American markets namely Brazil and Mexico, British brokerage firm Barclays has said.
-
Generic Opportunities to Drive Indian Pharma Sector Growth: Icra
With many drugs going off patent in the US, Indian pharma companies would continue to experience strong growth in American market, credit rating agency Icra has said.
-
US Pharma Companies Eye Opportunities Under Modi Government
The incoming government led by Narendra Modi represents an 'excellent opportunity' for American industries to strengthen and rekindle their relationships with India, a leading US industry body has said.
-
Pharma Exports to US to Remain Unaffected by Import Alerts: India Ratings
Indian pharmaceutical exports to the US are expected to keep growing despite a spate of import alerts issued by the American drug regulator in 2013, according to a report by India Ratings & Research.
-
Indian Envoy Meets Top CEOs Of US To Help Country In Covid Crisis
The Indian envoy in the US is having an intense engagement with the CEOs of top American companies, particularly from the pharma sector, to help India get the necessary medical equipment and drugs to successfully combat the COVID-19 pandemic.
-
India Reaches Out To US Companies Over Investment In Pharma Sector
India has reached out to top American pharma companies seeking investment in the country's pharmaceutical and medical devices sector, which gains urgency in view of a devastating second wave of the coronavirus pandemic.
-
US Pharma Firm Gilead To Donate 4.5 Lakh Remdesivir Vials To India
American biopharmaceutical company Gilead has announced steps to expand the availability of remdesivir, a key therapeutic medicine used in the treatment of COVID-19 patients, in India.
-
India May Not Get Pfizer Covid Vaccine, Cleared By UK, Anytime Soon: Sources
The coronavirus vaccine developed by American pharma giant Pfizer, which was cleared by the United Kingdom Wednesday and will be rolled out to the public early next week, is unlikely to be available in India at this time, sources have told NDTV
-
After H-1B, Strong Rupee The New Worry For Indian Tech Companies
For information technology and drug companies already contending with an American clampdown on working visas and a wave of unfavorable inspections by the U.S. Food and Drug Administration, rupee strength is another headache.
-
Natco Jumps 9% As Partner Mylan Inc Gets USFDA Nod
Natco Pharma shares surged nearly 9 per cent on Friday after the company said its marketing partner Mylan Inc has received tentative approval from the US health regulator for selling generic Sorafenib tablets, used for cancer treatment, in the American market.
-
Foreign Investors Holding In BSE200 Companies Drops To $291 Billion In Q4
Foreign Portfolio Investors (FPIs) have lowered their holding in BSE-200 companies to $291 billion during the January-March quarter and heavy selling was seen in sectors like banking and pharma, says a report.
-
Aurobindo Pharma Gets Final USFDA Nod For Anti-viral Drug
Aurobindo Pharma has received final approval from the US health regulator to manufacture and market anti-viral Valganciclovir tablets in the American market.
-
Cipla Inks Pact With US Firm for Post-Operative Pain Treatment Product
Drug major Cipla has inked a pact with US-based BioQ Pharma for registration and commercialisation of the American company's Ropivacaine infusion system, used in treating post-operative pain, in India.
-
Brazil's Downgrade to 'Junk' Hits Indian Pharma, Power Shares
Standard & Poor's downgrade of Brazil to "junk" hit those Indian companies that have exposure to the troubled Latin American country.
-
US Regulator Issues Import Alert on Aarti Drugs' 2 Plants
Aarti Drugs on Tuesday said its two manufacturing facilities have received import alert from the US Food and Drug Administration, a development which could impact the company's exports to the American market.
-
Indian Pharma Firms Should Tap Latin American Markets: Barclays
Indian pharmaceutical companies need to focus on the Latin American markets namely Brazil and Mexico, British brokerage firm Barclays has said.
-
Generic Opportunities to Drive Indian Pharma Sector Growth: Icra
With many drugs going off patent in the US, Indian pharma companies would continue to experience strong growth in American market, credit rating agency Icra has said.
-
US Pharma Companies Eye Opportunities Under Modi Government
The incoming government led by Narendra Modi represents an 'excellent opportunity' for American industries to strengthen and rekindle their relationships with India, a leading US industry body has said.
-
Pharma Exports to US to Remain Unaffected by Import Alerts: India Ratings
Indian pharmaceutical exports to the US are expected to keep growing despite a spate of import alerts issued by the American drug regulator in 2013, according to a report by India Ratings & Research.
